Poster 30
- Jun 5, 2023
- 1 min read
Dupilumab Demonstrates a Significantly Higher Likelihood of Achieving Improvements in Atopic Dermatitis Signs and Itch vs Nemolizumab at Week 16 in Combination With Topical Corticosteroids: Results From a Bucher Placebo-Adjusted Indirect Comparison
Martin Steinhoff, DirkJan Hijnen, Vimal H. Prajapati, Jensen Yeung, Patricia Guyot, Yann Cabon, Yingxin Xu, Zhixiao Wang, Kerry Noonan, Mike Bastian


